Profile
BGLC DHR-PB TMO DHR IDXX A
Company Name BioNexus Gene Lab Corp. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $3.49M $916.76B $203.95B $153.12B $51.47B $36.74B
Employees 0.03K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Su-Leng Tan Rainer M. Blair Marc N. Casper Rainer Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
BGLC DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
BGLC DHR-PB TMO DHR IDXX A
Last Close $4.68 $1261.26 $567.16 $220.44 $669 $144.52
High 52 $11.14 $1261.26 $606.74 $250.59 $722.94 $152.6
Low 52 $0.23 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -57.99 % 0 % -6.52 % -12.03 % -7.46 % -5.29 %
Price vs. 52 Week Low 1934.78 % 0 % 45.35 % 26.23 % 85.3 % 45.55 %
Total Return
BGLC DHR-PB TMO DHR IDXX A
1 Month Return -8.77 % 0 % 5.24 % 5.44 % 5.29 % 1.83 %
3 Month Return -12.11 % 0 % 16.29 % 5.47 % 4.88 % 22.32 %
6 Month Return 64.21 % 0 % 37.64 % 12.41 % 29.13 % 27.03 %
9 Month Return 1210.92 % 0 % 8.42 % 7.78 % 48.98 % 6.89 %
YTD Return 1573.22 % 0 % 9.02 % -3.97 % 61.81 % 7.58 %
1 Year Return 1538.66 % 0 % 11.4 % -4.51 % 60.69 % 14.98 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BGLC DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.59 % 0.32 % 0.59 % - 0.77 %
Dividend Paid and Capex Coverage Ration (TTM) -71.21 % 3.15 % 3.62 % 3.15 % 9.48 % 2.26 %
Dividend Per Share (TTM) - 1.28 % 1.72 % 1.28 % - 1 %
Payout Ratio (TTM) - 24.29 % 9.47 % 24.29 % - 21.64 %
Profitability
BGLC DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 14.77 % 60.93 % 39.46 % 60.93 % 61.8 % 52.43 %
Return on Assets TTM -30.14 % 4.33 % 6.09 % 4.33 % 31.62 % 10.24 %
Return on Equity TTM -30.19 % 6.99 % 13.14 % 6.99 % 69.78 % 20.62 %
Return on Capital Employed TTM -33.82 % 6.7 % 8.41 % 6.7 % 61.76 % 14.25 %
Net Income Per EBT TTM 96.89 % 85.38 % 92.39 % 85.38 % 80.01 % 90.8 %
EBT Per Ebit TTM 100.94 % 82.4 % 90.83 % 82.4 % 97.36 % 97.03 %
EBIT Per Revenue TTM -24.81 % 20.91 % 17.96 % 20.91 % 31.6 % 21.29 %
Cash Flow To Debt Ratio TTM -1550.82 % 34.84 % 19.85 % 34.84 % 1575.85 % 46.48 %
Receivables Turnover TTM 5.82 6.28 5.01 6.28 7.79 4.67
Payables Turnover TTM 43.7 5.2 - 5.2 14.89 5.8
Inventory Turnover TTM 8.01 3.86 4.97 3.86 4.35 3.22
Fixed Asset Turnover TTM 538.81 % 444.19 % 421.73 % 444.19 % 575.84 % 343.45 %
Asset Turnover TTM 124.19 % 29.44 % 40.38 % 29.44 % 128.44 % 54.59 %
Operating Cash Flow Per Share TTM -1.59 9.07 20.79 9.07 14.75 5.51
Free Cash Flow Per Share TTM -1.61 7.44 16.74 7.44 13.2 4.07
Cash Per Share TTM 161.12 % 652.48 % 2687.5 % 652.48 % 224.82 % 632.16 %
Operating Cash Flow Sales Ratio TTM -30.11 % 26.12 % 17.55 % 26.12 % 27.46 % 22.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.4 % 81.98 % 80.49 % 81.98 % 89.45 % 73.89 %
Cash Flow Coverage Ratios TTM -1550.82 % 34.84 % 19.85 % 34.84 % 1575.85 % 46.48 %
Price To Free Cash Flows Ratio TTM -1.21 29.11 32.41 29.11 48.69 31.89
Price To Operating Cash Flows Ratio TTM -1.22 23.88 26.11 23.88 43.69 23.52
Price Cash Flow Ratio TTM -1.22 23.88 26.11 23.88 43.69 23.52
Income Statement (TTM)
BGLC DHR-PB TMO DHR IDXX A
Revenue $0.01B $24.57B $44.56B $24.57B $4.3B $6.95B
Gross Profit $0B $14.97B $16.78B $14.97B $2.66B $3.64B
Gross Profit Ratio 13.56% 60.93% 37.66% 60.93% 61.8% 52.43%
EBITDA $-0B $6.95B $10.89B $6.95B $1.47B $1.84B
Net Income $-0B $3.61B $6.74B $3.61B $1.06B $1.3B
EPS Diluted -0.9 5.04 17.74 5.04 13.08 4.57
Balance Sheet (MRQ)
BGLC DHR-PB TMO DHR IDXX A
Long Term Debt $0B $18.42B $35.85B $18.42B $0.37B $3.05B
Total Liabilities $0B $30.93B $56.81B $30.93B $1.75B $5.99B
Total Equity $0.01B $52.54B $53.54B $52.54B $1.61B $6.74B
Total Investments $0B $0B $0.25B $0B $0B $0.13B
Total Debt $0B $18.42B $39.39B $18.42B $0.85B $3.35B
Total Assets $0.01B $83.46B $110.34B $83.46B $3.35B $12.73B
Cash Flow Statement (TTM)
BGLC DHR-PB TMO DHR IDXX A
Net Income $-0B $3.61B $6.72B $3.61B $1.06B $0.43B
Inventory $-0B $-0.06B $0B $-0.06B $0B $0.05B
Dividends Paid $0B $-0.88B $-0.64B $-0.88B $0B $-0.28B
Operating Cash Flow $-0B $6.42B $7.82B $6.42B $1.18B $1.56B
Capital Expenditure $-0B $-1.16B $-1.53B $-1.16B $-0.12B $-0.41B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 128.9
ACRS Aclaris Therapeutics, Inc. 3.385
ADVB Advanced Biomed Inc. Common Stock 0.255
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 5.62
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 10.369
BIAF bioAffinity Technologies, Inc. 0.993
BIAFW bioAffinity Technologies, Inc. 0.25
BIOC Biocept, Inc. 0.4349
BLLN BillionToOne, Inc. 85.5
BNGO Bionano Genomics, Inc. 1.125
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 28.88
CDNA CareDx, Inc 19.71
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 1.68
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 165.96
Unlock